Nucleotrace's Convertible Note Round

Nucleotrace raised a round of funding on October 09, 2017. Investors include Startmate.

Nucleotrace is developing supply chain monitoring software to combat drug counterfeiting by embedding pharmaceuticals with synthetic DNA encoded with the drug's product information.…

Articles about Nucleotrace's Convertible Note Round: